Berry Street’s new GLP-1 nutrition program supports patients who are starting GLP-1s, currently taking them or transitioning off of them. Patients receive care from registered

Do GLP-1 drugs like Ozempic & Wegovy cause hair loss? A new study is sparking concern that weight loss and insulin management drugs, such as

WE are taught to brush our teeth from a young age for a bright smile and fresh breath. And while those things are true, there

The pharmaceutical industry suffers from all of the issues that plaque heavily regulated industries that have been heavily regulated for a long time. Costs increase,

WEIGHT loss jabs could be given to children as young as six to treat obesity or type 2, researchers suggest. But stomach problems were “significantly

An expert committee concluded that GLP-1 drugs are integral to developing a global standard of care for obesity, according to draft guidance from the agency.

This industry perspective is by Justine Allan, Executive Director of Strategic Business Development at Pearlfisher. Not too long ago, taste was everything. Snacks earned loyalty,

By MEGAN TAGAMI of Honolulu Civil Beat, CAROLYN JONES of CalMatters and TATIANA DÍAZ RAMOS of Centro de Periodismo Investigativo LAHAINA, Hawaii (AP) — Mia

Half of people who start taking the GLP-1 weight-loss drugs Ozempic and Wegovy drop it within a year, Danish researchers reported at a conference in

We are entering a new era of obesity. The science of weight loss has changed forever: Drugs like Ozempic, Wegovy, and Mounjaro are helping millions

Plus, news about Revvity, Ocugen and Kwangdong: 🏛️ FDA expands label for Krystal Biotech’s gene therapy: Vyjuvek, which is used to treat a skin condition

Shares of Regeneron Pharmaceuticals (REGN) have lost 21.1% year to date against the industry’s growth of 5.2%. The stock has also underperformed the sector and

This systematic review and meta-analysis assesses the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in children and adolescents with obesity, prediabetes, or

This Perspective explores recent progress and future directions in glucagon-like peptide-1 medicines.

A HIGHER ‘golden dose’ of Wegovy than is currently approved is safe and could be more effective – helping patients lose nearly a fifth of

Semaglutide is linked to significant weight loss and glucose levels in adults with schizophrenia, overweight/obesity, and prediabetes compared with placebo, new research shows. Medscape Medical

More than half the adults in Denmark without diabetes have discontinued semaglutide for weight loss within a year, with young adults most likely to stop

Most quit breakthrough weight-loss drug within a year  ScienceDaily Half of people on weight loss drugs quit within one year, study finds  Euronews.com Top concern about Ozempic-like

By Dennis Thompson HealthDay ReporterMONDAY, Sept. 15, 2025 (HealthDay News) — Half of people who start taking the GLP-1 weight-loss drug Ozempic…

“Yes, luck would be easier to blame things on,” I nodded. “Luck is something outside of our control. It is popular, because it allows us

RAND Corporation GLP-1 agonists are a class of medications that are prescribed to manage blood sugar for those with type 2 diabetes and to treat

ALL medications, including prescription drugs, over-the-counter medicines, and even herbal remedies, have the potential to cause side effects. But experts have warned weight loss jab

Last week on Malwarebytes Labs: Introduction to Malware Binary Triage (IMBT) Course Looking to level up your skills? Get 10% off using coupon code: MWNEWS10

Last week on Malwarebytes Labs: AI browsers or agentic browsers: a look at the future of web surfing From Fitbit to financial despair: How one

The 64-year-old funnywoman – who’s won two Emmy Awards – has never admitted to taking a trendy GLP-1 agonist drug